| Q55261423 | Binding of sulphonylureas to plasma proteins - A KATP channel perspective. |
| Q34233297 | Binding of tolbutamide to glycated human serum albumin |
| Q58545208 | Binding studies based on ultrafast affinity extraction and single- or two-column systems: Interactions of second- and third-generation sulfonylurea drugs with normal or glycated human serum albumin |
| Q33876316 | Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography |
| Q34189372 | Chromatographic analysis of acetohexamide binding to glycated human serum albumin |
| Q36783827 | Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin |
| Q57464227 | Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns |
| Q37950599 | Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II). |
| Q67541498 | Drug-protein binding kinetics in patients with type I diabetes |
| Q58212783 | Glucose Modification of Human Serum Albumin: A Structural Study |
| Q73035359 | Glycation of human serum albumin by acylglucuronides of nonsteroidal anti-inflammatory drugs of the series of phenylpropionates |
| Q38349051 | Lactosylation of albumin reduces uptake rate of dibromosulfophthalein in perfused rat liver and dissociation rate from albumin in vitro |
| Q67882541 | Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats |
| Q36747287 | Protein binding of digitoxin, valproate and phenytoin in sera from diabetics |
| Q37192112 | Protein glycation and oxidative stress in diabetes mellitus and ageing |
| Q37227387 | Review: Glycation of human serum albumin |
| Q26829605 | Review: modifications of human serum albumin and their binding effect |
| Q49170312 | Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients |
| Q41850025 | The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum |
| Q39662366 | The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs |